Unit information prior for incorporating real-world evidence into randomized controlled trials

被引:0
作者
Zhang, Hengtao [1 ]
Yin, Guosheng [1 ,2 ]
机构
[1] Univ Hong Kong, Dept Stat & Actuarial Sci, Hong Kong, Peoples R China
[2] Univ Hong Kong, Dept Stat & Actuarial Sci, Pokfulam Rd, Hong Kong, Peoples R China
关键词
Clinical trials; evidence synthesis; informative prior; observational studies; summary statistics; PROPENSITY-SCORE; METAANALYSIS;
D O I
10.1177/09622802221133555
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Randomized controlled trials (RCTs) have been widely recognized as the gold standard to infer the treatment effect in clinical research. Recently, there has been growing interest in enhancing and complementing the result in an RCT by integrating real-world evidence from observational studies. The unit information prior (UIP) is a newly proposed technique that can effectively borrow information from multiple historical datasets. We extend this generic approach to synthesize the non-randomized evidence into a current RCT. Not only does the UIP only require summary statistics published from observational studies for ease of implementation, but it also has clear interpretations and can alleviate the potential bias in the real-world evidence via weighting schemes. Extensive numerical experiments show that the UIP can improve the statistical efficiency in estimating the treatment effect for various types of outcome variables. The practical potential of our UIP approach is further illustrated with a real trial of hydroxychloroquine for treating COVID-19 patients.
引用
收藏
页码:229 / 241
页数:13
相关论文
共 38 条
  • [11] Ho DE, 2011, J STAT SOFTW, V42
  • [12] Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study
    Ip, Andrew
    Berry, Donald A.
    Hansen, Eric
    Goy, Andre H.
    Pecora, Andrew L.
    Sinclaire, Brittany A.
    Bednarz, Urszula
    Marafelias, Michael
    Berry, Scott M.
    Berry, Nicholas S.
    Mathura, Shivam
    Sawczuk, Ihor S.
    Biran, Noa
    Go, Ronaldo C.
    Sperber, Steven
    Piwoz, Julia A.
    Balani, Bindu
    Cicogna, Cristina
    Sebti, Rani
    Zuckerman, Jason
    Rose, Keith M.
    Tank, Lisa
    Jacobs, Laurie
    Korcak, Jason
    Timmapuri, Sarah L.
    Underwood, Joseph P.
    Sugalski, Gregory
    Barsky, Carol
    Varga, Daniel W.
    Asif, Arif
    Landolfi, Joseph C.
    Goldberg, Stuart L.
    [J]. PLOS ONE, 2020, 15 (08):
  • [13] Jenkins D, 2021, Arxiv, DOI arXiv:1805.06839
  • [14] Unit information prior for adaptive information borrowing from multiple historical datasets
    Jin, Huaqing
    Yin, Guosheng
    [J]. STATISTICS IN MEDICINE, 2021, 40 (25) : 5657 - 5672
  • [15] Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making
    Katkade, Vaibhav B.
    Sanders, Kafi N.
    Zou, Kelly H.
    [J]. JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2018, 11 : 295 - 304
  • [16] Propensity-score-based priors for Bayesian augmented control design
    Lin, Junjing
    Gamalo-Siebers, Margaret
    Tiwari, Ram
    [J]. PHARMACEUTICAL STATISTICS, 2019, 18 (02) : 223 - 238
  • [17] Propensity score matched augmented controls in randomized clinical trials: A case study
    Lin, Junjing
    Gamalo-Siebers, Margaret
    Tiwari, Ram
    [J]. PHARMACEUTICAL STATISTICS, 2018, 17 (05) : 629 - 647
  • [18] Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data
    Liu, Meizi
    Bunn, Veronica
    Hupf, Bradley
    Lin, Junjing
    Lin, Jianchang
    [J]. STATISTICS IN MEDICINE, 2021, 40 (22) : 4794 - 4808
  • [19] Liu N., 2021, BMC MED RES METHODOL, V21, P1
  • [20] Determining the effective sample size of a parametric prior
    Morita, Satoshi
    Thall, Peter F.
    Mueller, Peter
    [J]. BIOMETRICS, 2008, 64 (02) : 595 - 602